Fusion genes are often oncogenes, such as BCR:ABL in chronic myeloid leukaemia (CML), TMPRSS2:ERG in prostate cancer, EML4:ALK in non-small-cell lung cancer (NSCLC) and so on. Here, EML4 is linked to non-small cell lung carcinoma.